I propose to take Questions Nos. 3179 and 3326 together.
Up to 7 July, the Health Products Regulatory Authority (HPRA) received 11,445 reports describing suspected side effects in association with COVID-19 vaccines, of which 6,011 were in association with mRNA vaccines (Comirnaty and Spikevax (previously COVID-19 Vaccine Moderna)), 5,361 in association with Adenoviral vector vaccines (Vaxzevria and Covid-19 Vaccine Janssen) and 73 reports were in association with vaccines where the brand was not known or provided at the time of reporting.
The majority of regularly reported suspected side effects are consistent with the types of events typically observed following vaccination, including those described in the product information for the individual vaccines. Whilst not experienced by everyone, all vaccines have some side effects, the vast majority of which are mild to moderate in nature. These side effects need to be continuously balanced against the benefits in preventing COVID-19 illness. Overall, the national reporting experience continues to support the favourable assessment that the benefits of COVID-19 vaccines outweigh the risks.
The HPRA has been publishing regular public safety updates on reporting experience with the COVID-19 vaccines, including information on the numbers and nature of these reports. To date, nine such updates have been published and are accessible from the HPRA website (www.hpra.ie/homepage/medicines/covid-19-updates/covid-19-vaccine-communications) with the most recent publication issued on 15th July.